Charles Magness
Director/Board Member at Kineta One LLC
Net worth: 329 439 $ as of 2024-06-29
Charles Magness active positions
| Companies | Position | Start | End |
|---|---|---|---|
Kineta One LLC
 Kineta One LLC Pharmaceuticals: MajorHealth Technology Kineta One LLC provides biotechnology services. The company is headquartered in Seattle, WA. | Director/Board Member | - | - |
Career history of Charles Magness
Former positions of Charles Magness
| Companies | Position | Start | End |
|---|---|---|---|
Illumigen Biosciences, Inc.
 Illumigen Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Illumigen Biosciences, Inc. provides pharmaceutical research services. It develops human genetic mutations that provide roadmap for therapeutic drug mechanisms. The company's product IB657 helps to investigate the cause of apparent immunity to HCV infection. Illumigen Biosciences was founded by Dr. Charles Magness and Shawn Iadonato in 2000 and is located in Seattle, WA | Chief Operating Officer | 2006-12-31 | 2006-12-31 |
| Founder | 2006-12-31 | 2006-12-31 | |
| President | - | 2006-12-31 | |
| KINETA, INC. | Chief Executive Officer | 2007-12-31 | - |
| Founder | 2007-12-31 | - | |
| President | 2007-12-31 | - | |
KPI Therapeutics, Inc.
 KPI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KPI Therapeutics, Inc. operates as a clinical stage biotechnology company, which develops first in class therapies for unmet medical needs in autoimmunity. It offers dalazatide, KPI-150, and KPI-190 for systemic autoimmune diseases including lupus; and CSP conopeptide for chronic pain. The company was founded in 2013 and is headquartered in Seattle, WA. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| President | - | - | |
| McDonnell Douglas Automation | Corporate Officer/Principal | - | - |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Kineta, Inc. (Washington)
 Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Chief Executive Officer | 2009-09-16 | - |
| Founder | 2009-09-16 | - | |
| President | 2009-09-16 | - |
Training of Charles Magness
| Lehigh University | Doctorate Degree |
Statistics
International
| United States | 9 |
Operational
| President | 4 |
| Chief Executive Officer | 3 |
| Founder | 3 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| KINETA, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Health Technology |
| McDonnell Douglas Automation | |
Illumigen Biosciences, Inc.
Illumigen Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Illumigen Biosciences, Inc. provides pharmaceutical research services. It develops human genetic mutations that provide roadmap for therapeutic drug mechanisms. The company's product IB657 helps to investigate the cause of apparent immunity to HCV infection. Illumigen Biosciences was founded by Dr. Charles Magness and Shawn Iadonato in 2000 and is located in Seattle, WA | Health Technology |
KPI Therapeutics, Inc.
KPI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KPI Therapeutics, Inc. operates as a clinical stage biotechnology company, which develops first in class therapies for unmet medical needs in autoimmunity. It offers dalazatide, KPI-150, and KPI-190 for systemic autoimmune diseases including lupus; and CSP conopeptide for chronic pain. The company was founded in 2013 and is headquartered in Seattle, WA. | Health Technology |
Kineta One LLC
Kineta One LLC Pharmaceuticals: MajorHealth Technology Kineta One LLC provides biotechnology services. The company is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Charles Magness
- Experience
